Horm Metab Res 1998; 30(12): 730-736
DOI: 10.1055/s-2007-978968
Originals Clinical

© Georg Thieme Verlag Stuttgart · New York

Comparative Effects of the Selective Estrogen Receptor Modulators (-)-, (+)- and (±)-Z-Bisdehydrodoisynolic Acids on Metabolic and Reproductive Parameters in Male and Female Rats

W. J. Banz1 , 2 , T. A. Winters1 , 2 , Y. Hou3 , S. Adler4 , 5 , C. Y. Meyers3
  • 1Department of Animal Science, Food and Nutrition, Southern Illinois University, Carbondale, IL, USA
  • 2Department of Physiology, Southern Illinois University, Carbondale, IL, USA
  • 3Department of Chemistry and Biochemistry, Southern Illinois University, Carbondale, IL, USA
  • 4Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO, USA
  • 5Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO, USA
Further Information

Publication History

1998

1998

Publication Date:
20 April 2007 (online)

Abstract

Doisynolic acids are non-steroidal estrogenic compounds originally obtained from alkali fusion of estrone and equilenin. Z-bisdehydrodoisynolic acids (Z-BDDA) exhibit a low binding affinity accompanied by a disproportionately high biologic activity. Two experiments were designed to investigate the chronic effects of (+)-, (-)- and (±)-Z-BDDA and (+)-17β-estradiol (E2) in male and female rats. The (+)-, (-)- and (±)-forms Z-BDDA were prepared and injected, daily for four to six weeks into male and female rats and changes in body weight, food intake, metabolic parameters, and reproductive parameters were investigated. Results from both experiments demonstrate that in male and female rats, (+)- and (±)-Z-BDDA had similar estrogenic effects on reproductive organ weight. Surprisingly, (-)-Z-BDDA did not induce the increase in uterine weight observed with (+)- and (±)-Z-BDDA and E2, demonstrating selective estrogen receptor modulation (SERM). Beneficial metabolic effects, although compound- and gender-specific, included a significant weight repression, reduction in cholesterol, reduction in blood glucose, and positive alterations in body fat distribution. Future research defining the optimal dosages of (-)-Z-BDDA that will maximize beneficial effects and minimize undesirable effects on reproductive tissues will lead to more efficacious treatment options for endocrine-responsive conditions in males and females.

    >